Disc Medicine to Participate in Upcoming Investor Conferences
Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in hematologic disease treatments, has announced its participation in four major investor conferences in September 2025.
The company will engage in fireside chats at the Cantor Fitzgerald Global Healthcare Conference (Sept 3, 10:55 AM ET), Wells Fargo Healthcare Conference (Sept 4, 4:30 PM ET), H.C. Wainwright Global Investment Conference (Sept 9, 12:00 PM ET), and Morgan Stanley Global Healthcare Conference (Sept 10, 1:05 PM ET). All sessions will be accessible via webcast through Disc Medicine's investor relations website.
Disc Medicine (NASDAQ:IRON), azienda biofarmaceutica in fase clinica specializzata in trattamenti per malattie ematologiche, ha annunciato la sua partecipazione a quattro importanti conferenze per investitori a settembre 2025.
La società terrà sessioni di tipo "fireside chat" al Cantor Fitzgerald Global Healthcare Conference (3 set, ore 10:55 ET), al Wells Fargo Healthcare Conference (4 set, ore 16:30 ET), all'H.C. Wainwright Global Investment Conference (9 set, ore 12:00 ET) e al Morgan Stanley Global Healthcare Conference (10 set, ore 13:05 ET). Tutti gli incontri saranno disponibili in webcast tramite il sito per gli investitori di Disc Medicine.
Disc Medicine (NASDAQ:IRON), una compañía biofarmacéutica en fase clínica especializada en tratamientos para enfermedades hematológicas, ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025.
La empresa participará en charlas tipo "fireside" en la Cantor Fitzgerald Global Healthcare Conference (3 sept, 10:55 AM ET), la Wells Fargo Healthcare Conference (4 sept, 4:30 PM ET), la H.C. Wainwright Global Investment Conference (9 sept, 12:00 PM ET) y la Morgan Stanley Global Healthcare Conference (10 sept, 1:05 PM ET). Todas las sesiones estarán disponibles por webcast a través del sitio de relaciones con inversores de Disc Medicine.
Disc Medicine (NASDAQ:IRON), 혈액 질환 치료를 전문으로 하는 임상 단계의 바이오제약 회사가 2025년 9월에 열리는 주요 투자자 콘퍼런스 네 곳에 참가한다고 발표했습니다.
회사 측은 Cantor Fitzgerald Global Healthcare Conference(9월 3일, 오전 10:55 ET), Wells Fargo Healthcare Conference(9월 4일, 오후 4:30 ET), H.C. Wainwright Global Investment Conference(9월 9일, 정오 12:00 ET), 및 Morgan Stanley Global Healthcare Conference(9월 10일, 오후 1:05 ET)에서 파이어사이드 채팅에 참여할 예정입니다. 모든 세션은 Disc Medicine 투자자 관계 웹사이트를 통해 웹캐스트로 시청할 수 있습니다.
Disc Medicine (NASDAQ:IRON), une société biopharmaceutique en phase clinique spécialisée dans les traitements des maladies hématologiques, a annoncé sa participation à quatre grandes conférences investisseurs en septembre 2025.
La société participera à des "fireside chats" lors de la Cantor Fitzgerald Global Healthcare Conference (3 sept., 10h55 ET), de la Wells Fargo Healthcare Conference (4 sept., 16h30 ET), de la H.C. Wainwright Global Investment Conference (9 sept., 12h00 ET) et de la Morgan Stanley Global Healthcare Conference (10 sept., 13h05 ET). Toutes les sessions seront accessibles en webcast via le site relations investisseurs de Disc Medicine.
Disc Medicine (NASDAQ:IRON), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Behandlung hämatologischer Erkrankungen spezialisiert hat, hat seine Teilnahme an vier großen Investorenkonferenzen im September 2025 angekündigt.
Das Unternehmen wird in Form von "Fireside Chats" auf der Cantor Fitzgerald Global Healthcare Conference (3. Sept., 10:55 Uhr ET), der Wells Fargo Healthcare Conference (4. Sept., 16:30 Uhr ET), der H.C. Wainwright Global Investment Conference (9. Sept., 12:00 Uhr ET) und der Morgan Stanley Global Healthcare Conference (10. Sept., 13:05 Uhr ET) vertreten sein. Alle Sitzungen sind per Webcast über die Investor-Relations-Website von Disc Medicine zugänglich.
- None.
- None.
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:
- Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 3rd at 10:55 a.m. ET.
- 2025 Wells Fargo Healthcare Conference on Thursday, September 4th at 4:30 p.m. ET.
- H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9th at 12:00 p.m. ET.
- Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10th at 1:05 p.m. ET.
Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.
Media Contact
Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com
Investor Relations Contact
Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com
FAQ
When is Disc Medicine (IRON) presenting at the Cantor Fitzgerald Healthcare Conference 2025?
How can investors access Disc Medicine's (IRON) conference presentations in September 2025?
What is Disc Medicine's (IRON) main business focus?
Which investor conferences will Disc Medicine (IRON) attend in September 2025?
